Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
2(50.0%)
4Total
N/A(2)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07524218Not ApplicableNot Yet Recruiting

Effect of Meal Timing During Adjuvant Treatment for Cancer

Role: collaborator

NCT06802172Not ApplicableRecruiting

Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial

Role: collaborator

NCT00139113Phase 4Completed

Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children

Role: collaborator

NCT00141999Completed

Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents

Role: collaborator

NCT00144313Phase 4Completed

VaxTeen Hepatitis B Vaccine Booster Study

Role: collaborator

All 5 trials loaded